Normal c-abl gene protein--a nuclear component.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Oncogene

• Publication date

  1991-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1886716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Establishment of a lymphoblastoid cell line, SD-1, expressing the p190 bcr-abl chimaeric protein.

  1991cited by this paper
• GTPase-activating protein interactions with the viral and cellular Src kinases.

  1991cited by this paper
• Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.

  1990cited by this paper
• Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases

  1990cited by this paper
• Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity.

  1990cited by this paper
• Immunocytochemical evaluation abl-Gene products in Leukemic Cell Lines

  1990cited by this paper
• BCR-ABL and BCR proteins: biochemical characterization and localization.

  1990cited by this paper
• The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization.

  1989cited by this paper
• N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl.

  1989cited by this paper
• Deletion of an N‐terminal regulatory domain of the c‐abl tyrosine kinase activates its oncogenic potential.

  1989cited by this paper
• Nucleotide sequence analysis of human abl and bcr-abl cDNAs.

  1989cited by this paper
• Identification of two normal bcr gene products in the cytoplasm.

  1988cited by this paper
• Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction.

  1988cited by this paper
• Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia

  1987cited by this paper
• cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia.

  1987cited by this paper
• The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia

  1987cited by this paper
• Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein

  1986cited by this paper
• Alternative 5' exons in c-abl mRNA.

  1986cited by this paper
• Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.

  1985cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

  1984cited by this paper
• A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro

  1984cited by this paper
• Detection of the v-abl gene product at cell-substratum contact sites in Abelson murine leukemia virus-transformed fibroblasts

  1984cited by this paper
• Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia

  1983cited by this paper
• Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

  1982cited by this paper
• Immunofluorescence on avian sarcoma virus-transformed cells: localization of the src gene product.

  1979cited by this paper

• Molecular pathogenesis of Philadelphia-positive chronic myeloid leukemia - is it all BCR-ABL?

  2011cites this paper
• Towards cure of CML: why we need to know more about CML stem cells?

  2009cites this paper
• Molecular and functional studies of the BCR/ABL1 fusion gene

  2006cites this paper
• Molecular and functional studies of the BCR / ABL 1 fusion gene

  2006cites this paper
• MOLECULAR AND FUNCTIONAL STUDIES OF THE BCR/ABL1 FUSION GENE

  2006cites this paper
• Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry.

  2002cites this paper
• The BCR gene and philadelphia chromosome-positive leukemogenesis.

  2001cites this paper
• In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.

  2000cites this paper
• Leucémie myéloïde chronique

  1999cites this paper
• A BCR-ABL(p190) fusion gene made by homologous recombination causes B-cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product.

  1997cites this paper
• Retroviral Vector Design for Gene Therapy of Cancer: Specific Inhibition and Tagging of BCR-ABLp190 Cells

  1996cites this paper
• Protein phosphorylation and dephosphorylation in physiologic and oncologic processes.

  1996cites this paper
• Cellular and Molecular Aspects of Myeloid Cell Proliferation and Development

  1996cites this paper
• Retroviral VectorDesignforGene TherapyofCancer:Specific Inhibition andTaggingofBCR-ABLP'90 Cells

  1996cites this paper
• CHUK, a new member of the helix-loop-helix and leucine zipper families of interacting proteins, contains a serine-threonine kinase catalytic domain.

  1995cites this paper
• Human c-FES is a nuclear tyrosine kinase.

  1995cites this paper
• Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

  1995cites this paper
• Cell cycle arrest by tyrosine kinase Abl involves altered early mitogenic response.

  1995cites this paper
• Subcellular localization of a protein-tyrosine phosphatase: evidence for association with chromatin.

  1994cites this paper
• Bcr‐Abl oncoproteins bind directly to activators of the Ras signalling pathway.

  1994cites this paper
• Structural alterations in the carboxyl-terminal domain of the BCRABL gene product activate its fibroblastic transforming potential.

  1994cites this paper
• ABL-BCR mRNAs transcribed from chromosome 9q+ in Philadelphia-chromosome-positive chronic myeloid leukaemia.

  1993cites this paper
• En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

  1993cites this paper
• Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.

  1993cites this paper
• Hormone‐conditional transformation by fusion proteins of c‐Abl and its transforming variants.

  1993cites this paper
• Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms

  1992cites this paper
• Multiple cDNAsEncoding theeskKinase Predict Transmembrane andIntracellular EnzymeIsoforms

  1992cites this paper